Nitric oxide-releasing oxatriazole derivatives inhibit human lymphocyte proliferation by a cyclic GMP-independent mechanism

Journal of Pharmacology and Experimental Therapeutics

Volumn 286, Issue 1, 1998, Pages 215-220

  Kosonen, Outi ^a,b   Kankaanranta, Hannu ^a,b   Lähde, Mari ^a   Vuorinen, Pauli ^a,b   Ylitalo, Pauli ^a,b   Moilanen, Eeva ^a,b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

3 (3,4 DICHLOROPHENYL) 1,2,3,4 OXATRIAZOLE 5 IMINE; 8 BROMO CYCLIC GMP; CYCLIC GMP; GUANYLATE CYCLASE INHIBITOR; ISOBUTYLMETHYLXANTHINE; NITRIC OXIDE; ZAPRINAST;

ARTICLE; CONCENTRATION RESPONSE; DRUG POTENTIATION; ENZYME INHIBITION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL;

1-METHYL-3-ISOBUTYLXANTHINE; CYCLIC GMP; GUANYLATE CYCLASE; HUMANS; LYMPHOCYTE ACTIVATION; NITRIC OXIDE; TRIAZOLES;

EID: 0031847459     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Ahmann GB, Sachs DH and Hodes RJ (1978) Requirement for an Ia-bearing accessory cell in Con A-induced T cell proliferation. J Immunol 121:1981-1989.
2. Albina JE, Abate JA and Henry WL Jr (1991) Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-stimulated T cell proliferation: Role of IFN-γ in the induction of the nitric oxide-synthesizing pathway. J Immunol 147:144-148.
3. Beavo JA (1995) Cyclic nucleotide phosphodiesterases: Functional implications of multiple isoforms. Physiol Rev 75:725-748.
4. Corell T, Pedersen SB, Lissau B, Moilanen E, Metsä-Ketelä T, Kankaanranta H, Vuorinen P, Vapaatalo H, Rydell E, Andersson R, Marcinkiewicz E, Korbut R and Gryglewski RJ (1994) Pharmacology of mesoionic oxatriazole derivatives in blood, cardiovascular and respiratory systems. Pol J Pharmacol 46:553-566.
5. Etienne P, Pares-Herbute N and Monnier L (1996) Enhanced antiproliferative effect of nitric oxide in cultured smooth muscle cells from diabetic rats. J Cardiovasc Pharmacol 27:140-146.
6. Fecho K, Maslonek KA, Dykstra LA and Lysle DT (1995) Mechanisms whereby macrophage-derived nitric oxide is involved in morphine-induced suppression of splenic lymphocyte proliferation. J Pharmacol Exp Ther 272:477-483.
7. Feelisch M (1993) Biotransformation to nitric oxide of organic nitrates in comparison to other nitrovasodilators. Eur Heart J 14(Suppl. I):123-132.
8. Garthwaite J, Southam E, Boulton CL, Nielsen EB, Schmidt K and Mayer B (1995) Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-α]quinoxalin-1-one. Mol Pharmacol 48:184-188.
9. Hersey P, Schibeci S and Cheresh D (1989) Augmentation of lymphocyte responses by monoclonal antibodies to the gangliosides GD3 and GD2: The role of protein kinase C, cyclic nucleotides, and intracellular calcium. Cell Immunol 119:263-278.
10. Ignarro LJ (1991) Signal transduction mechanisms involving nitric oxide. Biochem Pharmacol 41:485-490.
11. Järvinen TAH, Moilanen T, Järvinen TLN and Moilanen E (1995) Nitric oxide mediates interleukin-1-induced inhibition of glycosaminoglycan synthesis in rat articular cartilage. Med Inflammation 4:107-111.
12. Kankaanranta H, Luomala M, Kosonen O and Moilanen E (1996b) Inhibition by fenamates of calcium influx and proliferation of human lymphocytes. Br J Pharmacol 119:487-494.
13. Kankaanranta H, Rydell E, Petersson AS, Holm P, Moilanen E, Corell T, Karup G, Vuorinen P, Pedersen SB, Wennmalm Å and Metsä-Ketelä T (1996a) Nitric oxide-donating properties of mesoionic 3-aryl substituted oxatriazole-5-imine derivatives. Br J Pharmacol 117:401-406.
14. Karup G, Preikschat H, Wilhelmsen ES, Pedersen SB, Marcinkiewicz E, Cieslik K and Gryglewski RJ (1994) Mesoionic oxatriazole derivatives: A new group of NO-donors. Pol J Pharmacol 46:541-552.
15. Kosonen O, Kankaanranta H, Vuorinen P and Moilanen E (1997) Inhibition of human lymphocyte proliferation by nitric oxide-releasing oxatriazole derivatives. Eur J Pharmacol 337:55-61.
16. Lejeune P, Lagadec P, Onier N, Pinard D, Ohshima H and Jeannin J-F (1994) Nitric oxide involvement in tumor-induced immunosuppression. J Immunol 152:5077-5083.
17. Lepoivre M, Chenais B, Yapo A, Lemaire G, Thelander L and Tenu JP (1990) Alteratíon of ribonucleotide reductase activity following induction of the nitrite-generating pathway in adenocarcinoma cells. J Biol Chem 266:14143-14149.
18. Lincoln TM, Komavilas P, Boerth NJ, MacMillan-Crow LA and Cornwell TL (1995) cGMP signaling through cAMP- and cGMP-dependent protein kinases. Adv Pharmacol 34:305-322.
19. MacMicking J, Xie Q and Nathan C (1997) Nitric oxide and macrophage function. Annu Rev Immunol 15:323-350.
20. Malo-Ranta U, Ylä-Herttuala S, Metsä-Ketelä T, Jaakkola O, Moilanen E, Vuorinen P and Nikkari T (1994) Nitric oxide donor GEA 3162 inhibits endothelial cell-mediated oxidation of low density lipoprotein. FEBS Lett 337:179-183.
21. Marcinkiewicz J, Grabowska A and Chain BM (1996) Is there a role for nitric oxide in regulation of T cell secretion of IL-2? J Immunol 156:4617-4621.
22. Maw WW, Shimizu T, Sato K and Tomioka H (1997) Further study on the roles of the effector molecules of immunosuppressive macrophages induced by mycobacterial infection in expression of their suppressor function against mitogen-stimulated T cell proliferation. Clin Exp Immunol 108:26-33.
23. Merryman PF, Clancy RM, He XY and Abramson SB (1993) Modulation of human T cell responses by nitric oxide and its derivative, S-nitrosoglutathione. Arthritis Rheum 36:1414-1422.
24. Mills CD (1991) Molecular basis of 'suppressor' macrophages: Arginine metabolism via the nitric oxide synthetase pathway. J Immunol 146:2719-2723.
25. Moilanen E, Arola O, Malo-Ranta U, Ylä-Herttuala S, Vuorinen P, Metsä-Ketelä T and Vapaatalo H (1994) Nitric oxide donors inhibit neutrophil adhesion to endothelial cells. In The Biology of Nitric Oxide, ed. by Moncada S, Feelisch M, Busse R and Higgs, EA, Vol. 4, pp. 271-275, Portland Press, London.
26. Moilanen E, Moilanen T, Knowles R, Charles I, Kadoya Y, Al-Saffar N, Revell PA and Moncada S (1997) Nitric oxide synthase is expressed in human macrophages during foreign body inflammation. Am J Pathol 150:881-887.
27. Moilanen E and Vapaatalo H (1995) Nitric oxide in inflammation and immune response. Ann Med 27:359-367.
28. Moilanen E, Vuorinen P, Kankaanranta H, Metsä-Ketelä T and Vapaatalo H (1993) Inhibition by nitric oxide-donors of human polymorphonuclear leucocyte functions. Br J Pharmacol 109:852-858.
29. Moncada S and Higgs EA (1995) Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J 9:1319-1330.
30. Moncada S, Palmer RMJ and Higgs EA (1991) Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 43:109-141.
31. Mulsch A, Busse R, Liebau S and Förstermann U (1988) LY 83583 interferes with the release of endothelium-derived relaxing factor and inhibits soluble guanylate cyclase. J Pharmacol Exp Ther 247:283-288.
32. Radziszewski W, Chopra M, Zembowicz A, Gryglewski R, Ignarro LJ and Chaudhuri G (1995) Nitric oxide donors induce extrusion of cyclic GMP from isolated human blood platelets by a mechanism which may be modulated by prostaglandins. Int J Cardiol 51:211-220.
33. Schleifer KW and Mansfield JM (1993) Suppressor macrophages in African trypanosomiasis inhibit T cell proliferative responses by nitric oxide and prostaglandins. J Immunol 151:5492-5503.
34. Sicher SC, Vazquez MA and Lu CY (1994) Inhibition of macrophage Ia expression by nitric oxide. J Immunol 153:1293-1300.
35. Stadler J, Billiar TR, Curran RD, Stuehr DJ, Ochoa JB and Simmons RL (1991) Effect of exogenous and endogenous nitric oxide on mitochondrial respiration of rat hepatocytes. Am J Physiol 260:C910-C916.
36. Sutherland EW, Robison GA and Butcher RW (1968) Some aspects of the biological role of adenosine 3′,5′-monophosphate (cyclic AMP). Circulation 37:279-306.
37. Tjörnhammar ML, Lazaridis G and Bartfai T (1983) Cyclic GMP efflux from liver slices. J Biol Chem 258:6882-6886.
38. Vilpo JA, Vilpo LM, Vuorinen P, Moilanen E and Metsä-Ketelä T (1994) Cytotoxicity of mesoionic oxatriazoles: A novel series of nitric oxide donors. In The Biology of Nitric Oxide, ed. by Moncada S, Feelisch M, Busse R and Higgs, EA, Vol. 4, pp. 286-291, Portland Press, London.
39. Virta M, Karp M and Vuorinen P (1994) Nitric oxide donor-mediated killing of bioluminescent Escherichia coli. Antimicrob Agents Chemother 38:2775-2779.
40. Yang W, Ando J, Korenaga R, Toyo-oka T and Kamiya A (1994) Exogenous nitric oxide inhibits proliferation of cultured vascular endothelial cells. Biochem Biophys Res Commun 203:1160-1167.